News

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis
Illumina Inc. (NASDAQ: ILMN) today unveiled PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory ...